ICAM5 and relapsing-remitting multiple sclerosis: Interestingly, although there was no significant difference in ICAM-5 levels between NIND and RRMS patients, there was a strong negative correlation between EDSS and ICAM-5 concentration in the CSF of RRMS patients, which supports our hypothesis.